Get started
Author

Barbara Cebula‐Obrzut

Observed names: B. CEBULA-OBRZUT, B. Cebula, B. Cebula-Obrzut, BARBARA CEBULA-OBRZUT, Barbara Cebula, Barbara Cebula- Obrzut, Barbara Cebula-Obrzut, Cebula-Obrzut, Barbara
ORCID: 0000-0002-2689-7130
Observed ORCID: 0000-0002-2689-7130
OpenAlex ID: A5009157742
Cladribine combined with high doses of arabinoside cytosine, mitoxantrone, and G‐CSF (CLAG‐M) is a highly effective salvage regimen in patients with refractory and relapsed acute myeloid leukemia of the poor risk: a final report of the Polish Adult Leukemia Group
2007 · Agnieszka Wierzbowska, Tadeusz Robak, et al. · European Journal Of Haematology · 143
Sulforaphane Alone and in Combination with Clofarabine Epigenetically Regulates the Expression of DNA Methylation-Silenced Tumour Suppressor Genes in Human Breast Cancer Cells
2015 · Katarzyna Lubecka-Pietruszewska, Agnieszka Kaufman-Szymczyk, et al. · Lifestyle Genomics · 76
Expression and prognostic significance of the inhibitor of apoptosis protein (IAP) family and its antagonists in chronic lymphocytic leukaemia
2010 · Olga Grzybowska-Izydorczyk, Barbara Cebula, et al. · European Journal of Cancer · 73
Expression of Toll-Like Receptors 3, 7, and 9 in Peripheral Blood Mononuclear Cells from Patients with Systemic Lupus Erythematosus
2014 · Agnieszka Klonowska-Szymczyk, Anna Wolska, et al. · Mediators of Inflammation · 65
PDF
Circulating endothelial cells in patients with acute myeloid leukemia
2005 · Agnieszka Wierzbowska, Tadeusz Robak, et al. · European Journal Of Haematology · 64
MDR1 (ABCB1) gene polymorphism C3435T is associated with P-glycoprotein activity in B-cell chronic lymphocytic leukemia.
2006 · Krzysztof Jamroziak, Ewa Balcerczak, et al. · PubMed · 54
Rituximab plus cladribine with or without cyclophosphamide in patients with relapsed or refractory chronic lymphocytic leukemia
2007 · Tadeusz Robak, Piotr Smolewski, et al. · European Journal Of Haematology · 50
PDF
Rituximab combined with cladribine or with cladribine and cyclophosphamide in heavily pretreated patients with indolent lymphoproliferative disorders and mantle cell lymphoma
2006 · Tadeusz Robak, Piotr Smolewski, et al. · Cancer · 49
Proapoptotic activity of alemtuzumab alone and in combination with rituximab or purine nucleoside analogues in chronic lymphocytic leukemia cells
2004 · Piotr Smolewski, Anna Szmigielska-Kaplon, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 45
In vitro cytotoxic effect of proteasome inhibitor bortezomib in combination with purine nucleoside analogues on chronic lymphocytic leukaemia cells
2005 · Markus Duechler, Anna Linke, et al. · European Journal Of Haematology · 38
Clofarabine, a novel adenosine analogue, reactivates DNA methylation-silenced tumour suppressor genes and inhibits cell growth in breast cancer cells
2013 · Katarzyna Lubecka-Pietruszewska, Agnieszka Kaufman-Szymczyk, et al. · European Journal of Pharmacology · 35
Polymorphisms of TNF and IL‐10 genes and clinical outcome of patients with chronic lymphocytic leukemia
2012 · Ewa Lech‐Maranda, Wojciech Mlynarski, et al. · Genes Chromosomes and Cancer · 33
Atypical Chronic Lymphocytic Leukemia—The Current Status
2023 · Tadeusz Robak, Anna Krawczyńska, et al. · Cancers · 31
PDF
Novel Clofarabine-Based Combinations with Polyphenols Epigenetically Reactivate Retinoic Acid Receptor Beta, Inhibit Cell Growth, and Induce Apoptosis of Breast Cancer Cells
2018 · Katarzyna Lubecka, Agnieszka Kaufman-Szymczyk, et al. · International Journal of Molecular Sciences · 31
PDF
CD38Gene Polymorphisms Contribute to Genetic Susceptibility to B-Cell Chronic Lymphocytic Leukemia: Evidence from Two Case-Control Studies in Polish Caucasians
2009 · Krzysztof Jamroziak, Zofia Szemraj, et al. · Cancer Epidemiology Biomarkers & Prevention · 31
PDF
Intravenous Immunoglobulin Replacement Therapy in the Treatment of Patients with Common Variable Immunodeficiency Disease: An Open-Label Prospective Study
2011 · Karolina Kasztalska, Maciej Ciebiada, et al. · Clinical Drug Investigation · 28
Correlation of Smac/DIABLO protein expression with the clinico-pathological features of breast cancer patients
2011 · P. PLUTA, B. CEBULA-OBRZUT, et al. · Neoplasma · 28
Rapamycin, the mTOR kinase inhibitor, sensitizes acute myeloid leukemia cells, HL-60 cells, to the cytotoxic effect of arabinozide cytarabine
2009 · Agnieszka Janus, Anna Linke, et al. · Anti-Cancer Drugs · 28
Multi-drug transporter MDR1 gene polymorphism and prognosis in adult acute lymphoblastic leukemia.
2005 · Krzysztof Jamroziak, Ewa Balcerczak, et al. · PubMed · 27
Influence of high expression of Smac/DIABLO protein on the clinical outcome in acute myeloid leukemia patients
2010 · Agnieszka Pluta, Agata Wrzesien-Kus, et al. · Leukemia Research · 26
No Influence of 3435C>T ABCB1 (MDR1) Gene Polymorphism on Risk of Adult Acute Myeloid Leukemia and P-glycoprotein Expression in Blast Cells
2006 · Krzysztof Jamroziak, Ewa Balcerczak, et al. · Therapeutic Drug Monitoring · 25
Additive cytotoxic effect of bortezomib in combination with anti-CD20 or anti-CD52 monoclonal antibodies on chronic lymphocytic leukemia cells
2006 · Piotr Smolewski, Markus Duechler, et al. · Leukemia Research · 24
Angiopoietins in haematopoietic stem cell mobilisation in patients with haematological malignancies.
1967 · Anna Szmigielska-Kaplon, Anna Krawczynska, et al. · Europe PMC (PubMed Central) · 23
Imbalance of Th17 and T-regulatory cells in peripheral blood and synovial fluid in treatment naïve children with juvenile idiopathic arthritis
2014 · Joanna Szymańska-Kałuża, Barbara Cebula-Obrzut, et al. · Central European Journal of Immunology · 22
PDF
Significance of Bax Expression in Breast Cancer Patients
2011 · Piotr Pluta, Piotr Smolewski, et al. · Polish Journal of Surgery · 22
Works count: 103
Citation count: 1,454
H-index: 23
I10-index: 46
Year
Topic
Type